药物基因组测试对重度抑郁症患者药物使用和医疗资源利用的现实影响
Andria L Del Tredici1, Holly L Johnson1, Brady DeHart2
1From the Myriad Genetics, Salt Lake City, UT.
Journal of clinical psychopharmacology
|April 17, 2025
概括
药物基因组 (PGx) 测试在严重抑郁症 (MDD) 患者中减少了显著的基因药物相互作用和医疗资源利用率. 这项研究表明,PGx测试可能会改善MDD治疗的结果.
科学领域:
- 药物基因组学 药物基因组学
- 精神病学是一个精神病学.
- 卫生经济学 卫生经济学
背景情况:
- 重度抑郁症 (MDD) 治疗可以通过药物基因组 (PGx) 测试来改善,特别是在治疗失败后.
- PGx测试的实际结果,包括基因药物相互作用 (GDI) 和医疗保健资源利用率 (HRU),没有得到充分的记录.
研究的目的:
- 调查PGx测试对显著GDI的影响.
- 在PGx测试后评估MDD患者HRU的变化.
主要方法:
- 关联了美国无标识索赔数据与成人MDD患者的多基因PGx测试结果.
- 根据GDI将药物分类为一致或不一致的药物.
- 比较HRU (住院,急诊室访问) 在PGx测试前后180天.
主要成果:
- 降低了PGx测试后具有显著GDI的患者比例 (26.1%至15.9%).
- 在PGx测试后显著降低整体HRU (P<0.001),不包括非精神病医院住院.
- 在不匹配到匹配和没有变化组中减少精神病医院住院;在所有组中减少了急诊室的访问.
结论:
- 在MDD患者中,PGx测试与显著的GDI和减少HRU的药物处方减少相关.
- 虽然PGx测试可能会影响这些积极结果,但回顾性设计限制了最终的因果结论.
相关概念视频
Antidepressant Drugs: Overview
316
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
316
Human Genetics
470
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
470
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
41
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
41
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Antidepressant Drugs: MAOIs and Other Agents
160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160
Drug Therapy
28
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
28


